ILUMYA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/ML
Prescription Only
Drug type: Therapeutic
ATC code: L04AC17
Dosage form: INJECTION, SOLUTION
Route of administration: SUBCUTANEOUS
Active ingredient: Tildrakizumab; Tildrakizumab
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Approval Date
2024-09-04
Approval Number
SIN17076P
Manufacturer
VETTER PHARMA-FERTIGUNG GmbH & Co. KG